Biogen Aktie
140,80 EUR -4,40 EUR -3,03 %
FSE
148,00 USD +0,63 USD +0,43 %
nachbörslichBTT
BTT
Werbung
Biogen Rating
Biogen Inc Aktie Moody's Rating
Baa2
C
A3
Aaa
Investmentwürdig - Hohe Sicherheit
Investmentwürdig - Mittlere Sicherheit
Nicht als Investment geeignet
Investmentwürdig - Mittlere Sicherheit
Nicht als Investment geeignet
| Rating | Baa2 | Rating Typ Bank Financial Strength Rating Insurance Financial Strength Rating Enhanced Rating Insured Rating Long-Term Bank Deposit Rating Long-Term OSO Rating Long-Term Debt Rating Money Market Fund Rating Modeled Shadow Rating Management Quality Rating Probability of Default Rating Pfd/Pref Stock Rating Prospective Pfd/Pref Rating Short-Term Bank Deposit Rating Speculative Grade Liquidity Rating Prospective LT Debt Rating Short-Term Insurance Financial Strength Rating Short-Term OSO Rating Servicer Quality Short-Term Debt Rating Lloyd´s Syndicate Performance Rating Underlying Rating Unknown - for conversion use only | Long-Term Debt Rating |
| Letzte Aktion | AFFIRM | Moody's Büro in | - |
Moody's Ratings Peer Group
| Aktie | Rating |
|---|---|
| Amgen Inc. | Baa1 |
| Bayer | Baa3 |
| Gilead Sciences Inc. | A3 |